Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Announce new cell-based service offering that combines their technologies.
October 21, 2020
By: Contract Pharma
Contract Pharma Staff
Reaction Biology, a drug discovery CRO with offices in Pennsylvania and Germany, and 4HF Biotec GmbH, a bioinformatics firm based in Freiburg, Germany, have announced a new cell-based service offering that combines Reaction Biology’s ProLiFiler cell assay service with 4HF’s Biomarker Analysis and MOA Finder tools. 4HF Biotech has built a comprehensive database including data from more than 1,800 preclinical samples comprising multiple cancer datasets that are integrated into a single platform for visualization and statistical analysis. The data relevant for the Biomarker Analysis Tool are mutations (whole-exome sequencing), gene copy numbers, and gene expression data. The MoA Finder tool aims to identify the mode of action (MoA) of the test compound by comparing the sensitivity profile of the drug candidate to that of known drugs. Results of Reaction Biology’s 140 cell line assay will be put through both tools of Biomarker Analysis and MOA Finder to give customers a comprehensive understanding of their drug candidates. For Biomarker Analysis, a correlation analysis is performed for each cell line to determine the correlation of the drug sensitivity to each gene with regard to the expression level, mutation status, and/or somatic copy number. For MoA Finder, the test compound’s sensitivity profile is compared to more than 700 drugs for which the Mode of Action is known. “This will give our customers deep insight into the likely genetic response to the drug candidates they test with us,” said Dr. Haiching Ma, chief science officer of Reaction Biology. “A cell profile study can shine a spotlight on what a compound is doing, but combining that with 4HF’s bioinformatics creates a roadmap for our customers’ further development.” “Seeing the phenotypic effects of a compound is only half the information required for an informed drug discovery decision,” added Dr. Vincent Vuaroqueaux, CSO of 4HF. “Our bioinformatic approach to building an oncological drug response profile will provide the other half. The Reaction Biology platform is the perfect application for our data analytics.” The service will be performed at Reaction Biology’s labs, collaborating with 4HF for analysis. Both companies’ labs are in Freiburg.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !